🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔬 Why do opportunistic infections still matter in the #HIV response? Join us tomorrow at 13:30 CEST for the 2nd part of our webinar series exploring TB Meningitis & Talaromyces marneffei. Interpretation in French, Spanish & Portuguese. ✍️ Register now! iasociety.zoom.us/webinar/regist…

⏰ Last call to save on your #IAS2025 registration! The IAS 2025 standard registration period closes today in less than 6 hours at 23:59 CEST. ✅ Secure your spot now and save on your registration! iasociety.org/conferences/ia…

Evaluating psychosocial experiences of participants in HIV cure research before, during, and after analytical treatment interruptions (ATI): A longitudinal qualitative study in the United States Co-author A/Prof Karine Dubé is DARE community rep #HIVcure doi.org/10.1016/j.socs…

#DYK Health information specialists from NIH OAR provide customized, confidential answers to your questions about #HIV and #AIDS clinical trials and treatment.📱Call 1-800-448-0440, Monday to Friday, 1-4 p.m. ET, or email [email protected] go.nih.gov/fiUIVTV

So proud of Anusha Nathan, PhD on this amazing achievement! So well deserved!!

Differences in HIV-1 reservoir size, landscape characteristics, and decay dynamics in acute and chronic treated HIV-1 Clade C infection Co-authors include DARE researcher Prof Mathais Lichterfeld #HIVcure buff.ly/veeX7Rr

It is important to protect yourself from #HIV. Here are some ways to prevent HIV: ✅Using condoms ✅Using #PrEp if you believe you are likely exposed to HIV ✅If you are exposed and haven’t taken PrEP consider taking #PEP within 72 hours Learn more: go.nih.gov/hHMxtHt

Happening TOMORROW! You still have time to register!

PREPRINT: Combination immunotherapy induces post-intervention control of #HIV Many DARE researchers are authors including senior author Associate Professor Rachel Rutishauser – Rachel Rutishauser (moving to bsky: rrutishauser) #HIVcure Michael Peluso, MD Demi Sandel buff.ly/VAODNoV

Intact #HIV DNA decays in children with and without complete viral load suppression Co-authors include DARE researcher Associate Professor Lillian Cohn "HIV is a difficult prognosis for children because it is deadly if untreated" #HIVcure buff.ly/If0YOzY

2019 Community HIV Cure Research Workshop youtu.be/Wpk4uq6YkG4?si… via YouTube #hivcure

#OTD (20 May) in 1983, Françoise Barré-Sinoussi and Luc Montagnier in France reported the discovery of a retrovirus that could be the cause of AIDS. Their discovery was crucial in improving treatment methods for people living with HIV. In 2008, they shared the medicine prize.

May is #HepatitisAwarenessMonth. Hepatitis C is spread mainly through contact with the blood of a person who has HCV. People with both #HIV and HCV may be treated for both infections. Learn more about #HIV and Hepatitis C: go.nih.gov/axIqHRT

HIV Tat as a latency reversing agent: turning the tables on viral persistence ‘Shock and kill’ for an #HIVcure uses latency reversing agents to reactivate latent #HIV with the aim to kill infected cells DARE researcher Sharon Lewin is co-author doi.org/10.3389/fimmu.…

Contribution of intact viral genomes persisting in blood and tissues during ART to plasma viral rebound in SHIV-infected rhesus macaques Persistent SIV/HIV reservoirs – the main obstacle to #HIVcure DARE researchers Profs Estes and Chomont are co-authors buff.ly/JSPfyuz

The 10th edition HIV-AIDS glossary is available. It provides a roadmap to understanding #HIV. Key features of the latest edition include: ✅ Images to illustrate several terms ✅ Definitions for more than 1k HIV/AIDS related terms To learn more: clinicalinfo.hiv.gov/sites/default/…

👥 Join thousands of #HIV researchers, advocates, policy makers and community leaders at #IAS2025, which kicks off 13 July in #Kigali and virtually! ✅ Register today and help shape the future of the HIV response! iasociety.org/conferences/ia…

🌍 #IAS2025 will take place in Africa at a critical time for progress in responding to #HIV – reflecting successes & challenges. It will showcase contributions of African HIV research & celebrate advances in HIV science on the continent! #AfricaDay iasociety.org/conferences/ia…

🌍 As the #HIV response navigates new challenges & opportunities, the #IAS2025 programme reflects the cutting-edge science, innovation & collaboration needed to move us forward. 📲 Check out the programme & join us in #Kigali or virtually! #AfricaDay programme.ias2025.org

Differential immunophenotype and proviral composition in young adults with perinatally acquired HIV DARE researchers Profs Yu and Lichterfeld are co-authors – Yu & Lichterfeld Labs @ Ragon doi.org/10.1097/QAD.00…